Baycol Lawsuit
In September 2003, a federal judge denied status of Baycol class
action lawsuits to several thousand claims because the Baycol
lawsuits were seen as being too diverse in issues and medical
conditions. While the Baycol lawsuit decision was viewed as a
positive for Bayer, with Bayer shares immediately rising, the
company had already paid $477 million to settle out of court 1,342
U.S. Baycol lawsuits. The company still faces over 11,000 Baycol
lawsuits.
Most of the Baycol lawsuits have been alleging instances of rhabdomyolysis,
a rare disease causing muscle damage, kidney failure, and other
injuries, including death. At the time of the Baycol recall, there
had been 416 cases of rhabdomyolysis linked to Baycol use. Bayer
has stated that its legal strategy would be to continue analyzing
specific circumstances in each of the Baycol lawsuits before agreeing
on what they found to be fair compensation for the particular
Baycol lawsuit.
In October 2002, over a year after the Baycol recall occurred,
a consumer advocacy group felt Bayer did not adequately inform
Baycol patients of the recalled drug. Since the Baycol drug was
a voluntary withdrawal, the FDA was not responsible for informing
patients of the safety move, and Bayer failed to as well according
to a study finding the lack of federal laws or regulation governing
this process did impact the patients informed. Bayer is still
facing 11,000 Baycol lawsuits pending, but the number of potential
Baycol lawsuits may increase even more if people are still unknowingly
using Baycol and suffering because of it.
For more Baycol lawsuit information contact
us to confer with a Baycol lawsuit lawyer.
Your Baycol Recall Information Source 